Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-05-12 @ 9:22 PM
Study NCT ID:
NCT04959305
Status:
COMPLETED
Last Update Posted:
2022-07-14
First Post:
2021-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
Sponsor:
Hanmi Pharmaceutical Company Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HM-APOLLO-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None